Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Candida albicans | 3 | 2025 | 90 | 0.450 |
Why?
|
| Killer Cells, Natural | 3 | 2022 | 351 | 0.410 |
Why?
|
| Candidiasis | 2 | 2025 | 137 | 0.380 |
Why?
|
| Viral Matrix Proteins | 2 | 2025 | 110 | 0.360 |
Why?
|
| Receptors, CXCR6 | 2 | 2022 | 11 | 0.340 |
Why?
|
| Influenza A virus | 2 | 2025 | 152 | 0.340 |
Why?
|
| Fungal Proteins | 2 | 2025 | 136 | 0.270 |
Why?
|
| CD11b Antigen | 1 | 2023 | 39 | 0.210 |
Why?
|
| Gastrointestinal Tract | 1 | 2025 | 232 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 140 | 0.190 |
Why?
|
| Mycoses | 1 | 2023 | 117 | 0.190 |
Why?
|
| Microglia | 1 | 2023 | 138 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2025 | 62 | 0.180 |
Why?
|
| Cell Plasticity | 1 | 2022 | 35 | 0.180 |
Why?
|
| Spleen | 2 | 2019 | 272 | 0.180 |
Why?
|
| Immunophenotyping | 1 | 2022 | 344 | 0.170 |
Why?
|
| Antibodies, Viral | 2 | 2025 | 1205 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 210 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 292 | 0.160 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 865 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 1038 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 263 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 195 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2021 | 325 | 0.150 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 94 | 0.140 |
Why?
|
| Immunologic Memory | 1 | 2019 | 199 | 0.140 |
Why?
|
| Antigens, Viral | 1 | 2019 | 439 | 0.130 |
Why?
|
| Cross Protection | 1 | 2017 | 7 | 0.130 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 57 | 0.130 |
Why?
|
| Liver | 2 | 2019 | 1806 | 0.110 |
Why?
|
| Biomarkers | 1 | 2022 | 3380 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2017 | 498 | 0.090 |
Why?
|
| Mutation | 1 | 2025 | 6249 | 0.090 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2022 | 266 | 0.080 |
Why?
|
| Mice | 5 | 2025 | 18566 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2025 | 60 | 0.060 |
Why?
|
| Sensation Disorders | 1 | 2024 | 24 | 0.060 |
Why?
|
| Symbiosis | 1 | 2025 | 103 | 0.060 |
Why?
|
| Cytokines | 2 | 2022 | 1367 | 0.050 |
Why?
|
| Animals | 5 | 2025 | 34953 | 0.050 |
Why?
|
| Epitopes | 1 | 2025 | 436 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cell Degranulation | 1 | 2022 | 29 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 234 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2025 | 501 | 0.050 |
Why?
|
| STAT5 Transcription Factor | 1 | 2022 | 89 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2022 | 413 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2021 | 189 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2021 | 98 | 0.040 |
Why?
|
| HIV Antigens | 1 | 2019 | 12 | 0.040 |
Why?
|
| Chickenpox | 1 | 2019 | 22 | 0.040 |
Why?
|
| Herpesvirus 3, Human | 1 | 2019 | 30 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 686 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 4541 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 97 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2025 | 700 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2019 | 155 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 122 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1613 | 0.040 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 810 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 356 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1253 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2019 | 437 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 140 | 0.030 |
Why?
|
| Cell Line | 1 | 2022 | 2730 | 0.030 |
Why?
|
| Gold | 1 | 2017 | 57 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2017 | 123 | 0.030 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2017 | 61 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 538 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 189 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2017 | 392 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1052 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 1017 | 0.030 |
Why?
|
| Humans | 5 | 2025 | 132105 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 3061 | 0.020 |
Why?
|
| Brain | 1 | 2024 | 3201 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3698 | 0.020 |
Why?
|
| Female | 2 | 2025 | 70680 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9940 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 21413 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 28936 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31557 | 0.010 |
Why?
|